05/23/2022

IVI and AHRI establish Collaborating Center for joint vaccine research, development, and capacity-building for global health

  May 23, 2022– SEOUL, Republic of Korea and ADDIS ABABA, Ethiopia – The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines, and Armauer Hansen Research Institute (AHRI), established by the Government of […]
06/03/2022

IVI welcomes Rwanda as a member state with flag-raising ceremony

06/07/2022

International Vaccine Institute and Egyptian Agency of Partnership for Development co-host symposium on African vaccine manufacturing

06/14/2022

Typhoid: Multi- and single-dose formulations of Vi-DT vaccine shown to be safe and immunologically equivalent in new study

New evidence supports the use of alternative dosing formulations, expanding TCV delivery options in public health programs     June 14, 2022 – SEOUL, Republic of Korea – A new study jointly conducted by the International Vaccine Institute (IVI) and collaborators shows multidose and single-dose […]